HRTX - Heron Therapeutics says chief development officer Forbes buys 50K shares in co
2023-11-20 11:35:20 ET
More on Heron Therapeutics
- Heron Therapeutics GAAP EPS of -$0.17 beats by $0.14, revenue of $31.43M misses by $0.4M
- Seeking Alpha’s Quant Rating on Heron Therapeutics
For further details see:
Heron Therapeutics says chief development officer Forbes buys 50K shares in co